Holen Sie sich die Stockscreener-App
81.83
0.90%
0.73
Handel nachbörslich:
81.83
Schlusskurs vom Vortag:
$81.10
Offen:
$80.92
24-Stunden-Volumen:
730.54K
Relative Volume:
0.98
Marktkapitalisierung:
$11.14B
Einnahmen:
$2.48B
Nettoeinkommen (Verlust:
$91.51M
KGV:
40.71
EPS:
2.01
Netto-Cashflow:
$293.77M
1W Leistung:
-0.20%
1M Leistung:
+12.33%
6M Leistung:
+27.07%
1J Leistung:
+79.57%
1-Tages-Spanne:
$80.69
$82.39
1-Wochen-Bereich:
$80.59
$83.74
52-Wochen-Spanne:
$44.02
$84.87
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Vergleichen Sie GMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| GMED | 81.83 | 11.14B | 2.48B | 91.51M | 293.77M | 2.01 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Globus Medical Stock: Re-Rated After A Solid Year (NYSE:GMED) - Seeking Alpha
Globus Medical, Inc. (NYSE:GMED) Shares Sold by Vaughan Nelson Investment Management L.P. - MarketBeat
Globus Medical (GMED) is a Top-Ranked Momentum Stock: Should You Buy? - Yahoo Finance
Globus Medical, Inc. (NYSE:GMED) Position Trimmed by Principal Financial Group Inc. - MarketBeat
Janus Henderson Group PLC Adjusts Stake in Globus Medical Inc - GuruFocus.com
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term - Yahoo Finance
Expanding Global Market, NuVasive Benefits to Aid GMED Stock - MSN
Is Globus Medical (GMED) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
Globus Medical's SWOT analysis: robotic surgery drives stock growth By Investing.com - Investing.com Nigeria
Globus Medical's SWOT analysis: robotic surgery drives stock growth - Investing.com
Globus Medical price target raised to $83 from $74 at Morgan Stanley - Yahoo Finance
Some May Be Optimistic About Globus Medical's (NYSE:GMED) Earnings - Yahoo Finance
Globus Medical (GMED) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Canada Finance
Globus Medical, Inc. (NYSE:GMED) Shares Purchased by Lisanti Capital Growth LLC - MarketBeat
Globus Medical (NYSE:GMED) Price Target Raised to $83.00 - MarketBeat
Insider Selling: Globus Medical, Inc. (NYSE:GMED) SVP Sells 5,000 Shares of Stock - MarketBeat
Globus Medical, Inc. (NYSE:GMED) CEO Daniel T. Scavilla Sells 60,000 Shares - MarketBeat
Van ECK Associates Corp Raises Stake in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical CEO sells $4.8 million in stock - Investing.com
Globus Medical's SVP Kelly Huller sells $405,050 in stock - Investing.com
Globus Medical's SVP Kelly Huller sells $405,050 in stock By Investing.com - Investing.com Nigeria
Globus Medical CEO sells $4.8 million in stock By Investing.com - Investing.com UK
FY2024 EPS Estimates for Globus Medical Raised by Analyst - MarketBeat
Q4 EPS Estimates for Globus Medical Reduced by Roth Capital - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Q3 2024 Earnings Call Transcript - Insider Monkey
Globus Medical Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
What 7 Analyst Ratings Have To Say About Globus Medical - Benzinga
Piper Sandler raises Globus Medical stock target on strong Q3 results - Investing.com Canada
BofA lifts Globus Medical stock outlook, notes cautious optimism amid NuVasive integration - Investing.com
Earnings call: Globus Medical reports robust Q3 growth, eyes 2025 prospects - Investing.com Canada
Globus Medical (NYSE:GMED) Price Target Raised to $100.00 - MarketBeat
Radnor Capital Management LLC Invests $2.14 Million in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical (NYSE:GMED) Receives "Hold" Rating from Needham & Company LLC - MarketBeat
Globus Medical (NYSE:GMED) Given New $80.00 Price Target at Bank of America - MarketBeat
Zacks Research Forecasts Higher Earnings for Globus Medical - MarketBeat
S&P 500 Futures Climb in Premarket Trading; Trump Media & Tech, Globus Medical Lead - Barron's
Globus Medical’s net sales increase 63.1% to USD 625.7M in Q3 2024 - Medical Buyer
Globus Medical (GMED) Beats Q3 Earnings and Revenue Estimates - MSN
Globus Medical rises 8% on raised 2024 guidance - MSN
Allspring Global Investments Holdings LLC Sells 512,559 Shares of Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical Reports Third Quarter 2024 Results - GlobeNewswire
Globus Medical Inc (GMED) Q3 2024 Earnings Call Highlights: Reco - GuruFocus.com
Globus Medical Inc (GMED) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
Decoding Globus Medical Inc (GMED): A Strategic SWOT Insight - GuruFocus.com
Globus Medical Reports Robust Q3 2024 Financial Growth - TipRanks
Globus Medical (GMED) Q3 2024 Earnings Call Transcript - Nasdaq
Globus Medical stock hits 52-week high at $76.06 By Investing.com - Investing.com Canada
Globus Medical (NYSE:GMED) Releases FY 2024 Earnings Guidance - MarketBeat
Globus Medical (GMED) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Globus Medical: Q3 Earnings Snapshot - San Antonio Express-News
Globus Medical (NYSE:GMED) Issues FY24 Earnings Guidance - MarketBeat
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):